Emerging functions of the EGFR in cancer
暂无分享,去创建一个
S. Sigismund | L. Lanzetti | D. Avanzato | Sara Sigismund | Daniele Avanzato | Letizia Lanzetti | Letizia Lanzetti
[1] Marie-Lena I. E. Harwardt,et al. Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy , 2017, eLife.
[2] P. P. Di Fiore,et al. Behind the Scenes: Endo/Exocytosis in the Acquisition of Metastatic Traits. , 2017, Cancer research.
[3] P. Bork,et al. The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR , 2016, The Journal of cell biology.
[4] M. McNiven,et al. A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. , 2006, Cancer research.
[5] A. Citri,et al. Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling , 2007, Oncogene.
[6] N. Sauvonnet,et al. Endophilin marks and controls a clathrin-independent endocytic pathway , 2014, Nature.
[7] John Foley,et al. Functional selectivity of EGF family peptide growth factors: implications for cancer. , 2009, Pharmacology & therapeutics.
[8] T. Tsakiridis,et al. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. , 2016, Metabolism: clinical and experimental.
[9] Kevin Carroll,et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) , 2005, The Lancet.
[10] A. Sobel,et al. The Journal of Biological Chemistry. , 2009, Nutrition reviews.
[11] J. Schlessinger,et al. Receptor tyrosine kinases: legacy of the first two decades. , 2014, Cold Spring Harbor perspectives in biology.
[12] C. Futter,et al. EGF receptor trafficking: consequences for signaling and cancer , 2014, Trends in cell biology.
[13] S. Sigismund,et al. Chapter Six - The Ubiquitin Network in the Control of EGFR Endocytosis and Signaling. , 2016, Progress in molecular biology and translational science.
[14] H. Kajiho,et al. RAB2A controls MT1‐MMP endocytic and E‐cadherin polarized Golgi trafficking to promote invasive breast cancer programs , 2016, EMBO reports.
[15] Xuejun Jiang,et al. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. , 2006, Molecular cell.
[16] C. A. Guyer,et al. Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells. , 2003, Experimental cell research.
[17] F. Ali-Osman,et al. EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis , 2011, Molecular Cancer.
[18] S. Keir,et al. EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity. , 2010, Cancer letters.
[19] A. Bardelli,et al. MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations , 2016, Science Translational Medicine.
[20] Y. Yarden,et al. Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. , 2016, Seminars in cell & developmental biology.
[21] S. Horvath,et al. EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy , 2009, Science Signaling.
[22] I. Pastan,et al. Kinetics of transit of transferrin and epidermal growth factor through clathrin-coated membranes , 1984, Cell.
[23] C. Futter,et al. Membrane contacts between endosomes and ER provide sites for PTP1B–epidermal growth factor receptor interaction , 2010, Nature Cell Biology.
[24] F. Bosch,et al. Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer , 2012, Nature Medicine.
[25] T. Miyake,et al. Epidermal Growth Factor Receptor Translocation to the Mitochondria , 2009, The Journal of Biological Chemistry.
[26] M. Moran,et al. Proteomic Analysis of the Epidermal Growth Factor Receptor (EGFR) Interactome and Post-translational Modifications Associated with Receptor Endocytosis in Response to EGF and Stress* , 2014, Molecular & Cellular Proteomics.
[27] A. Scott,et al. The Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor AG1478 Increases the Formation of Inactive Untethered EGFR Dimers , 2007, Journal of Biological Chemistry.
[28] Peter J Verveer,et al. Imaging Sites of Receptor Dephosphorylation by PTP1B on the Surface of the Endoplasmic Reticulum , 2002, Science.
[29] D. Yamazaki,et al. Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration. , 2003, Developmental cell.
[30] A. Takaoka,et al. Comparing antibody and small-molecule therapies for cancer , 2006, Nature Reviews Cancer.
[31] G. Carpenter,et al. All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*) , 1996, The Journal of Biological Chemistry.
[32] M. Oksvold,et al. UV-Radiation-Induced Internalization of the Epidermal Growth Factor Receptor Requires Distinct Serine and Tyrosine Residues in the Cytoplasmic Carboxy-Terminal Domain , 2004, Radiation research.
[33] A. Bardelli,et al. Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer , 2016, Nature Communications.
[34] B. van Deurs,et al. EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes. , 2007, Carcinogenesis.
[35] Shuichi Takayama,et al. Lateral propagation of EGF signaling after local stimulation is dependent on receptor density. , 2002, Developmental cell.
[36] M. Lisanti,et al. Epidermal Growth Factor Receptor Exposed to Oxidative Stress Undergoes Src- and Caveolin-1-dependent Perinuclear Trafficking* , 2006, Journal of Biological Chemistry.
[37] D. Hochhauser,et al. Stress-specific p38 MAPK activation is sufficient to drive EGFR endocytosis but not its nuclear translocation , 2017, Journal of Cell Science.
[38] Isabelle Robert,et al. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer , 2007, Proceedings of the National Academy of Sciences.
[39] A. Kiyatkin,et al. EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics , 2017, Cell.
[40] G. Voeltz,et al. Structure and function of ER membrane contact sites with other organelles , 2015, Nature Reviews Molecular Cell Biology.
[41] D. Wheeler,et al. The nuclear epidermal growth factor receptor signaling network and its role in cancer. , 2011, Discovery medicine.
[42] R. Derynck,et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor , 1995, Nature.
[43] G. Mills,et al. Genomic amplicons target vesicle recycling in breast cancer. , 2009, The Journal of clinical investigation.
[44] Sandra L Schmid,et al. Cargo and Dynamin Regulate Clathrin-Coated Pit Maturation , 2009, PLoS biology.
[45] R. Roskoski. The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.
[46] C. Pyke,et al. Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy. , 2010, Cancer research.
[47] J. Settleman,et al. EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling , 2012, Growth factors.
[48] E. Skarpen,et al. UV induces tyrosine kinase-independent internalisation and endosome arrest of the EGF receptor. , 2002, Journal of cell science.
[49] K. Dittmann,et al. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK , 2008, Molecular Cancer.
[50] M. Salido,et al. Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer , 2015, Clinical Cancer Research.
[51] N. Copeland,et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. , 1994, Genes & development.
[52] G. Carpenter,et al. Interaction of activated EGF receptors with coated pit adaptins. , 1993, Science.
[53] F. Hirsch,et al. Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies. , 2013, European journal of cancer.
[54] Yih-Leong Chang,et al. Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC , 2015, Oncotarget.
[55] Matthew West,et al. Endoplasmic reticulum–endosome contact increases as endosomes traffic and mature , 2013, Molecular biology of the cell.
[56] E. Wagner,et al. Strain-dependent epithelial defects in mice lacking the EGF receptor. , 1995, Science.
[57] Naveid A Ali,et al. The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking , 2015, Science Signaling.
[58] Davide Mazza,et al. Reticulon 3–dependent ER-PM contact sites control EGFR nonclathrin endocytosis , 2017, Science.
[59] A. Ciliberto,et al. Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells , 2015, Nature Communications.
[60] W. Bou-Assaly,et al. Cetuximab (Erbitux) , 2010, American Journal of Neuroradiology.
[61] Gordon B. Mills,et al. Derailed endocytosis: an emerging feature of cancer , 2008, Nature Reviews Cancer.
[62] Marino Zerial,et al. Rab Proteins and the Compartmentalization of the Endosomal System , 2014 .
[63] J. Hurley,et al. The ESCRT machinery at a glance , 2009, Journal of Cell Science.
[64] J. Schlessinger,et al. The EGFR family: not so prototypical receptor tyrosine kinases. , 2014, Cold Spring Harbor perspectives in biology.
[65] R. Puertollano,et al. Activation of p38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization , 2006, Traffic.
[66] H. Lo,et al. Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations. , 2012, Cancer letters.
[67] G. Scita,et al. Membrane and actin dynamics interplay at lamellipodia leading edge. , 2013, Current opinion in cell biology.
[68] Yan Luo,et al. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. , 2016, Cellular signalling.
[69] Sophie Dahan,et al. Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction. , 2016, Annual review of biochemistry.
[70] B. Shi,et al. EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer , 2017, Molecular Cancer.
[71] W. Cavenee,et al. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[72] K. Carraway,et al. Epidermal Growth Factor Receptor Activation under Oxidative Stress Fails to Promote c-Cbl Mediated Down-regulation* , 2002, The Journal of Biological Chemistry.
[73] J. Debnath,et al. Autophagy and cancer metabolism. , 2014, Methods in enzymology.
[74] H. Esumi,et al. Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma* , 2014, The Journal of Biological Chemistry.
[75] John Kuriyan,et al. An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor , 2006, Cell.
[76] M. Hung,et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity. , 2008, Cancer cell.
[77] G. Voeltz,et al. ER Contact Sites Define the Position and Timing of Endosome Fission , 2014, Cell.
[78] Y. Yarden,et al. The C‐terminus of the kinase‐defective neuregulin receptor ErbB‐3 confers mitogenic superiority and dictates endocytic routing , 1999, The EMBO journal.
[79] G. Mills,et al. Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments , 2007 .
[80] David Owen,et al. Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. , 2014, Cold Spring Harbor perspectives in biology.
[81] D. Hochhauser,et al. WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway , 2015, Nature Communications.
[82] M. McNiven,et al. Increased Expression of the Large GTPase Dynamin 2 Potentiates Metastatic Migration and Invasion of Pancreatic Ductal Carcinoma , 2011, Oncogene.
[83] Salvatore Pece,et al. Endocytosis and cancer. , 2004, Current opinion in cell biology.
[84] Harvey T. McMahon,et al. Molecular mechanism and physiological functions of clathrin-mediated endocytosis , 2011, Nature Reviews Molecular Cell Biology.
[85] P. Transidico,et al. Clathrin-independent endocytosis of ubiquitinated cargos. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[86] Tobias Meyer,et al. A polarized Ca2+, diacylglycerol, and STIM1 signaling system regulates directed cell migration , 2014, Nature Cell Biology.
[87] G. Mills,et al. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression. , 2016, Cancer research.
[88] Angeleen Fleming,et al. Compromised autophagy and neurodegenerative diseases , 2015, Nature Reviews Neuroscience.
[89] Y. Yarden,et al. Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[90] Z. Kam,et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.
[91] Y. Kalaidzidis,et al. Regulation of EGFR signal transduction by analogue-to-digital conversion in endosomes , 2015, eLife.
[92] Y. Yarden,et al. Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR , 2013, Proceedings of the National Academy of Sciences.
[93] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[94] N. Grishin,et al. EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance , 2013, Cell.
[95] G. Mills,et al. Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. , 2007, Developmental cell.
[96] Careen K. Tang,et al. Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII , 2006, Cancer biology & therapy.
[97] P. Bastiaens,et al. EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling , 2015, eLife.
[98] Corinne Silva,et al. Phosphorylation of Y845 on the Epidermal Growth Factor Receptor Mediates Binding to the Mitochondrial Protein Cytochrome c Oxidase Subunit II , 2004, Molecular and Cellular Biology.
[99] M. Prados,et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. , 2011, Cancer discovery.
[100] Edward S. Kim,et al. Epidermal growth factor receptor inhibition in lung cancer: status 2012. , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[101] K. Dittmann,et al. Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[102] C. Hoogenraad,et al. Right Time, Right Place: Probing the Functions of Organelle Positioning. , 2016, Trends in cell biology.
[103] Sharon E. Miller,et al. CALM Regulates Clathrin-Coated Vesicle Size and Maturation by Directly Sensing and Driving Membrane Curvature , 2015, Developmental cell.
[104] Stephanie J. Spielman,et al. Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2 , 2017, The Journal of cell biology.
[105] Jiangong Ren,et al. Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells , 2014, Cell cycle.
[106] B. Vincenzi,et al. The biological properties of cetuximab. , 2008, Critical reviews in oncology/hematology.
[107] P. De Camilli,et al. Endoplasmic Reticulum-Plasma Membrane Contact Sites. , 2017, Annual review of biochemistry.
[108] P. P. Di Fiore,et al. Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. , 2008, Developmental cell.
[109] Marcel Mettlen,et al. Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis. , 2017, Developmental cell.
[110] S. Hanash,et al. EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. , 2016, Cancer research.
[111] A. Berns,et al. Drugging the addict: non‐oncogene addiction as a target for cancer therapy , 2016, EMBO reports.
[112] C. Antonescu,et al. Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis , 2015, Molecular biology of the cell.
[113] J. Kuriyan,et al. A structural perspective on the regulation of the epidermal growth factor receptor. , 2015, Annual review of biochemistry.
[114] L. Cantley,et al. Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin. , 2017, Cell reports.
[115] S. Rhee,et al. Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.
[116] P. Bastiaens,et al. Single Particle Tracking Reveals that EGFR Signaling Activity Is Amplified in Clathrin-Coated Pits , 2015, PloS one.
[117] Y. Yarden,et al. The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors , 2015, Oncogene.
[118] D. Hochhauser,et al. EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. , 2011, Cancer research.
[119] Y. Yarden,et al. p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.
[120] Xiaojun Tan,et al. LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation , 2015, The EMBO journal.
[121] J. Denu,et al. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. , 1998, Biochemistry.
[122] I. Szumiel. Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence. , 2006, Cellular signalling.
[123] M. Satake,et al. Altered trafficking of mutated growth factor receptors and their associated molecules , 2014, Cellular logistics.
[124] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[125] J. Rathmell,et al. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. , 2008, Blood.
[126] R. Pazdur,et al. FDA drug approval summary: erlotinib (Tarceva) tablets. , 2005, The oncologist.
[127] D A Lauffenburger,et al. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. , 1994, The Journal of biological chemistry.
[128] H. Wiley,et al. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system , 1988, The Journal of cell biology.
[129] Y. Yarden,et al. A mutant EGF‐receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling , 2002, The EMBO journal.
[130] J. Rathmell,et al. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. , 2007, Molecular biology of the cell.
[131] Gur Pines,et al. The ERBB network: at last, cancer therapy meets systems biology , 2012, Nature Reviews Cancer.
[132] A. Ciliberto,et al. Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. , 2012, Physiological reviews.
[133] G. Scita,et al. A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination , 2014, The Journal of cell biology.
[134] J. Douillard,et al. Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status , 2015, Drugs.
[135] C. Futter,et al. An Endosomal NAADP-Sensitive Two-Pore Ca2+ Channel Regulates ER-Endosome Membrane Contact Sites to Control Growth Factor Signaling , 2017, Cell reports.
[136] Xiaojun Tan,et al. A Kinase-Independent Role for EGF Receptor in Autophagy Initiation , 2015, Cell.
[137] Yan Wang,et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2 , 2013, Nature.
[138] Navdeep S. Chandel,et al. Fundamentals of cancer metabolism , 2016, Science Advances.
[139] L. Orci,et al. Co-localization of 125I-epidermal growth factor and ferritin-low density lipoprotein in coated pits: a quantitative electron microscopic study in normal and mutant human fibroblasts , 1982, The Journal of cell biology.
[140] Rebecca A. Ihrie,et al. A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo. , 2017, Cell reports.
[141] S. Wiemann,et al. Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer , 2015, Science Signaling.
[142] Xiaojun Tan,et al. Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications. , 2016, Trends in cell biology.
[143] K. Herrup,et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.
[144] Seamus J. Martin,et al. Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.
[145] Harald Stenmark,et al. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins , 2009, Nature.
[146] Douglas L Black,et al. EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. , 2013, Cell metabolism.
[147] D. Rubinsztein,et al. Autophagy modulation as a potential therapeutic target for diverse diseases , 2012, Nature Reviews Drug Discovery.
[148] A. Ciliberto,et al. Threshold-controlled ubiquitination of the EGFR directs receptor fate , 2013, The EMBO journal.
[149] Y. Kalaidzidis,et al. Signal processing by the endosomal system. , 2016, Current opinion in cell biology.
[150] D. Sabatini,et al. Identification of an oncogenic RAB protein , 2015, Science.
[151] J. Bussink,et al. EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[152] C. Futter,et al. Annexin A1 Tethers Membrane Contact Sites that Mediate ER to Endosome Cholesterol Transport , 2016, Developmental cell.
[153] P. Mischel,et al. mTORC2 in the center of cancer metabolic reprogramming , 2014, Trends in Endocrinology & Metabolism.
[154] M. Schuldiner,et al. A Tether Is a Tether Is a Tether: Tethering at Membrane Contact Sites. , 2016, Developmental cell.
[155] A. Ballabio,et al. Molecular definitions of autophagy and related processes , 2017, The EMBO journal.
[156] Matthew Meyerson,et al. Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. , 2007, Cancer cell.
[157] G. Mills,et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers , 2004, Nature Medicine.
[158] S. Schmid. JCB_201705017 2623..2632 , 2017 .
[159] M. Jaramillo,et al. Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting. , 2006, Experimental cell research.
[160] Andrew J. Lindsay,et al. Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments , 2008, The Journal of cell biology.
[161] Suyong Choi,et al. PtdIns(4,5)P2 signaling regulates ATG14 and autophagy , 2016, Proceedings of the National Academy of Sciences.
[162] T. Ravid,et al. EGF Receptor Exposed to Oxidative Stress Acquires Abnormal Phosphorylation and Aberrant Activated Conformation That Impairs Canonical Dimerization , 2011, PloS one.
[163] Xuejun Jiang,et al. Grb2 regulates internalization of EGF receptors through clathrin-coated pits. , 2003, Molecular biology of the cell.
[164] Derek Toomre,et al. Spatial control of EGF receptor activation by reversible dimerization on living cells , 2010, Nature.
[165] P. P. Di Fiore,et al. Endocytic control of signaling at the plasma membrane. , 2016, Current opinion in cell biology.
[166] M. Pierotti,et al. Targeted Therapies: The Rare Cancer Paradigm , 2010, Molecular oncology.
[167] Sandra L Schmid,et al. Advances in analysis of low signal-to-noise images link dynamin and AP2 to the functions of an endocytic checkpoint. , 2013, Developmental cell.
[168] Mads Lerdrup,et al. Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor , 2009, Traffic.
[169] A. Lenferink,et al. Differential endocytic routing of homo‐ and hetero‐dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers , 1998, The EMBO journal.
[170] C. Arteaga,et al. Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding Site* , 1997, The Journal of Biological Chemistry.
[171] S. Gygi,et al. Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor , 2010, The Journal of cell biology.